4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000950170-24-097071
Chief Development Officer sold 16,041 shares at $4.74 ($75,975)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Machatha Stephen Chief Development Officer | 2024-08-12 | Sale | −16,041 | $4.74 | $75,975 | 236,771 | D: show line 1 in the form |
| Open-market sales · 16,041 sh · avg $4.74 · $75,975 | |||||||
Loading xslF345X05/ownership.xml…